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Decision: to do something about this!
How did this work start?
5th Workplace and Indoor Aerosol 
Conference, Cassino, Italy, April 2018
Lidia’s presentation: Ultrafine particles: two 
decades of research and the debate is still on!
As an adviser to the minister of 
health/environment…
• What are the concentration trends of UFP 
in your city/country (going up or down)?
….how would you answer the questions:
• What is their source apportionment?
• How to measure them?
• What standard values would you recommend?
• Do UFP cause health effects?
“While there is a considerable toxicological 
evidence of potential detrimental effects of 
UFP on human health, the existing body of 
epidemiological evidence is insufficient to 
conclude on exposure/response relationship to 
UF particles” 
WHO 2005
Health guidelines for UFP?
WHO: revision of the air quality 
health guidelines 
WHO Guidelines Development Group, 
Bonn, September 2015
New WHO AQ Guidelines: 2020?
Will they include UFP?
Next meeting: 4-6 June, Bonn
Randomized control trials? 
The Parachute
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Thinking outside the box
How do we work?
The White Paper – highly advanced
Epi meta analyses – starting before summer, 
manuscripts ready by the end of this year
Progress to date
Morawska et al, Ambient nano and ultrafine particles from motor vehicle
emissions: characteristics, ambient processing and implications on
human exposure. Atmospheric Environment, 42: 8113-8138, 2008.
Update of the 2008 review paper – starting 
before summer
Focus of this 
presentation
Sections of the paper
Current state of knowledge
What are ultrafine particles?
Why are ultrafine particles important?
General
Why are ultrafine particles a special
challenge?
The theories underpinning UFP emission and 
formation process are generally well developed;
Current state of knowledge
UFP and precursor emission inventories hardly exist.
Local understanding of the origin of UFP 
(secondary/primary, specific sources), or their chemical 
composition (solid/liquid, organic carbon/elemental carbon, 
metals, etc.) is generally very limited;  
Exposure: source emissions
The mechanisms/conditions affecting particle 
concentrations/trends ➔in general well understood; 
There is typically limited local data on UFP spatial and 
temporal concentrations.
A general agreement on what are low versus high 
concentrations (clean versus polluted) ➔ recommendation 
about ‘normal’ versus ‘abnormal’ concentrations;
Current state of knowledge
Exposure: UFP concentrations and 
spatial/temporal variation in cities
Particle number concentrations 




















































Morawska, et al. Atmospheric Environment, 42: 8113-8138, 2008
Clean environments: < 103
Urban background:  104





De Jesus et al. Ultrafine particles and PM2.5 in the air of cities around the world: how 
similar or different are their drivers? Environment International, Accepted 9 May 2019
Particle number concentrations 
in different environments: 2019 
PNC/PSD ➔ most commonly measured, relatively well 
established methods ➔ no standard methods selected; 
Current state of knowledge
Exposure: UFP measurement 
methods I
Proposal ➔ instruments measuring at least down to 10 nm,
no upper limit restriction. An error/uncertainly due to missing 
the first few nm needs to be established;
An uncertainty due the lack of absolute calibration methods 
for of instruments measuring PNC (of the order of 10% ➔
can be quantified);
How to transform the inter-quantitative data, or a factor 
converting this to say,104 particles/cm3 based on the 
measurement device? 
Due to the lack of adequate instrumental methods 
we cannot recommend UFP mass or surface area 
measurements as routine approaches; 
Exposure: UFP measurement 
methods II
We call for establishing of “supersites”.
Very little/no relationship between PNC and PM2.5 ➔ due to 
their different sources and behaviour in ambient air. Therefore, 
they are not representative of each other (local combustion process 
 mainly UFP, and mechanical process and production of SOA at regional 
scale  mainly PM2.5);
Exposure: relationship between 
UFP, other particle metrics and 
gaseous pollutants
Current state of knowledge
A better relationship between PNC and traffic emitted gaseous 
pollutants (CO and NOx) and BC; but, the existence/degree of the 
relationship vary ➔is specific to different urban environments.  
Annual median PNC and PM2.5
De Jesus et al. Ultrafine particles and PM2.5 in the air of cities around the world: how 
similar or different are their drivers? Environment International, Accepted 9 May 2019
General understanding of the sources/processes leading 
to indoor UFP; 
Some level of understanding of typical UFP concentrations in typical
indoor environments (typical ➔ restricted to the countries/setting of 
the studies);
Current state of knowledge
Often large differences in UPF concentration between specific and 
typical indoor environments (e.g. a specific and a typical school);
It is more logistically complicated to investigate UFP in indoor 
environments, however, since in general their sources are understood, 
recommendations can be provided regarding source control. 
Exposure: indoor versus outdoor 
UFP
The population exposure estimation to UFP in epi short/long-
term studies ➔ significantly more complex than for PM2.5/PM10
For some cities the temporal correlation among monitoring sites 
➔ comparable between PM2.5 and UFP, for others <  for UFP
PNC spatial variation across a city >> higher than of PM2.5/PM10

Epi long-term studies cannot adopt the approach of the PM2.5
studies relying on single/few central sites

Future studies: modelling or increasing the number of monitors
Current state of knowledge
Exposure: assessment for 
epidemiological studies I















































The difficulties in obtaining spatially resolved estimates of 
long-term exposure hamper progress in long-term epi studies 
on UFP (high cost of PNC monitors prohibits large-scale monitoring, almost no 
successful modelling approaches for UFP);
However, scientific progress on many fronts makes personal 
exposure assessment possible;
Current state of knowledge
Exposure: assessment for 
epidemiological studies II
There is a need to develop an optimal way of exposure 
assessment for epidemiological studies, utilising the 
emerging science and technology.
Exposure assessment to traffic UFP ➔ simultaneously with 
other traffic related exposures (such as to gases, BC or noise). 

They are not just co-variables (co-pollutants) ➔ have 
different pathways in the body, their effects are independent

How to do this well, so in the end we are not left without 
neither evidence for NO2, nor UFP, nor BC (because of all the 
uncertainty, and if mutually adjustments)? 
Current state of knowledge
Exposure: assessment for 
epidemiological studies III
Differences in size/distribution between UFP and larger particles ➔
regional differences in deposited dose, potentially ➔ to different biological 
responses. Focusing only on PM2.5 ➔ overlooking the impact of UFP
Toxicology: From exposure to 
internal dose
Current state of knowledge
Air
Lung deposited
The toxic potency of UFP when using mass as a dose descriptor often 
(but not always) differs from PM2.5, showing that UFP cause > effects. 
In the lung ➔ different response to UFP than to larger particles. 
Toxicology I
Current state of knowledge
Induction of oxidative stress in
pulmonary macrophages using different
size fraction of the ambient PM mixture
from an urban background or urban
heavy traffic area (Li et al., 2003)
The effect of size on clearance and retention of particles in 
the rat lung (Oberdörster 2004)
Toxicology II
For practical reasons, using PNC as a predictor may 
be preferred above mass and surface area. 
Toxicology: metric for the UFP
concentration-effect relationships? 
Current state of knowledge
But, increased understanding of the importance of 
chemical composition for toxicological effects of UFPs 
and the use of surface area rather than mass as dose 
metric may possibly shed more light on the issue. 
There are considerable differences in the toxic 
potency of UFP released from various sources 
when using mass as unifying metric.
Toxicology: does the toxicity of UFP 
depends on source?
Current state of knowledge
Shorter averaging times (< 24 h) seem relevant to 
determine the health impact of UFP ➔ but there is a 
lack of data from experimental studies. 
Toxicology: acute (peak) exposures)
versus long term UFP exposures 
and health impacts?
Current state of knowledge
At present, it is unknown whether (repeated) peak 
exposures are more relevant than continuous exposures 
to lower PNC, but with the same mean dose. 
Epidemiology I





Mortality 0 1 1
Morbidity 0 4 4
Emergency/hospital call/admission 0 0 0
Subclinical 0 5 5
All 0 10 10
Short-term





(Respiratory) Symptoms 8 11 19
Subclinical 52 55 107
All 86 78 164
Total 86 88 174
*HEI Perspective 3. 2013
** Ohlwein et al IJPH 2019
Since then, new studies on UFP exposures within hour/days:
➢ 3 on mortality, 
➢ 6 on lung function, 
➢ 1 on cardiac function
➢ 8 on blood biomarkers 
Epidemiology II
Current progress/state of knowledge
Advances made in reliably determining the spatial distribution ➔
to allow investigations of long-term health effects ➔ new studies 
published recently on long-term effects of UFP
The studies indicate:
➢ associations between PNC and cardiovascular morbidity 
➢ that the impact of UFP is independent of PM2.5 and NO2

Composition of diesel particles 
N = N1 + N2
New method
N – total particles
N1 – primary UFP + nucleating 
immediately after emission
N2 – secondary UFP low BC bearing particles
correlated with BC
➢ Mean UFP concentration similar in all 3 cities
➢ BC higher in Barcelona and Tenerife
➢ Association with daily mortality:
• In Barcelona and Tenerife with N1
• In Huelva with N2
(none of the associations were significant)
• UFPs do not affect respiratory health outcomes in children but 
do have systemic effects, detected in the form of a positive 
association with a biomarker for systemic inflammation. 
• This is consistent with the known propensity of UFPs to 
deposit deep into the lung and penetrate to the circulatory 
system. PNC: positively associated with an increase in CRP (1.188-fold change per 
1000 UFP cm-3 day/day (95% credible interval 1.077 to 1.299)) and an 
increase in FeNO among atopic participants (1.054 fold change per 1000 
UFP cm-3 day/day (95% CrI 1.005 to 1.106)).
• Beneficial effects of walking on lung function attenuated 
by air pollution
• Augmentation was associated UFP, NO2, BC and PM2.5
Epidemiology III
Current state of knowledge
Still ➔ an absence of quantitative meta-analyses
An underlying reason ➔ both exposure assessments and the 
study designs are very heterogeneous across studies
Therefore ➔ timely to reevaluate the overall evidence and 
consider different designs (time-series analyses, case-crossover 
studies, panel studies and quasi-experiments) using a systematic 





These analyses will consider:
➢ the heterogeneity of populations or patient groups studied
➢ the differences in UFP measurements
➢ the differences in exposure-response times (typically 
operationalized by lag-periods), 
➢ different years of investigation and related underlying time-
trends altering the sources and composition of UFP
These (challenging) quantitative meta-analyses will:
✓ provide novel insights
✓ impact on regulatory evaluations
✓ generate hypotheses to be tested in epidemiological studies, controlled 
human exposure and toxicological studies. 
The Parachute
Yeh et all, BMJ 2018;363:k5094




We hope that the outcome of this work will 
come in time to inform the WHO process 
